Opiant Pharmaceuticals Inc. | Mutual Funds
Mutual Funds that own Opiant Pharmaceuticals Inc.
Vanguard Total Stock Market Index Fund
59,762
2.22%
0
0%
07/31/2018
Vanguard Extended Market Index Fund
22,403
0.83%
0
0%
07/31/2018
iShares Micro Cap ETF
6,568
0.24%
0
0.01%
09/06/2018
Fidelity Spartan Extended Market Index Fund
3,215
0.12%
0
0%
07/31/2018
DFA US Small Cap Portfolio
2,884
0.11%
2,884
0%
04/30/2018
Vanguard Institutional Total Stock Market Index Fund
1,271
0.05%
0
0%
07/31/2018
DFA Tax Managed US Small Cap Portfolio
1,202
0.05%
1,202
0%
04/30/2018
Vanguard Balanced Index Fund
845
0.03%
0
0%
07/31/2018
431
0.02%
0
0.21%
07/13/2018
Highland Small Cap Equity Fund
0
0%
-12,800
0%
12/31/2017
| Address |
201 Santa Monica Boulevard
Santa Monica California 90401
United States
|
|
Employees
|
- |
| Website |
http://www.opiant.com |
| Updated |
07/08/2019 |
| Opiant Pharmaceuticals, Inc. is a biopharmaceutical company, which develops pharmaceutical solutions for common addictions and related disorders. The company focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. |
